Previous research has shown that cannabis use disorder (CUD) can be treated with a combination of counseling and cannabis medicines with a 1:1 ratio of CBD and THC. But men and people with sleep issues may benefit from additional support, new analysis suggests.
The study will involve 10 participants, aged between six months and 21 years, who all have severe symptoms from non-cancerous conditions, such as cerebral palsy, neurodegenerative disorders, and progressive cardiac disease.
In a notice published on October 4, the Department of Cannabis Control announced that the test will be limited to dried flower and pre-rolls.
Martha Hernández, a scientist at CloudLIMS, breaks down the seven requirements anyone should consider before starting a cannabis extraction facility.
Scientists have developed a new compound which interacts with the same therapeutic targets in the brain as psychedelic drugs, producing the same long-lasting antidepressant and antianxiety effects but without the psychedelic high.
California’s cannabis regulator will provide $20 million in funding for new cannabis-related research.
James Rucker, a consultant psychiatrist at King's College London, breaks down the good psychedelic research from the bad. via the Conversation.